There is a strong support area around $9.5 - $10.5 Could be a good opportunity if it keeps respecting the limits. Technical data RSI @42 (waiting for this indicator to go higher) OBV reaching for higher highs Bollinger bandwith relatively high. Not buying yet, but it's worth it to keep on your watchlist.
There is a good RRR to enter XBI today. We seem to be in a bullish channel (showed in chart). IMMU - Which is 1.5% of the sector, is also a good option. (higher risk - higher reward).
After recapturing its 200 DMA a week ago on meaningful volume, the shares of MARKER THERAPEUTICS INC - NASDAQ;MRKR have found themselves consolidating the recent move in a constructive and orderly manner as is evidenced in the Daily chart above. With the stock now trading above all of its important moving averages 20/50/200 DMA's, the technical posture is...
After recapturing its 200 DMA in early Spring (March), shares of CYTOKINETICS INC - NASDAQ;CYTK have been grinding into higher ground as we can observe in the Daily chart above. Additionally, CYTK continues to trade above all of its important moving averages 20/50/200 DMA's, suggestive of a favorable technical posture. Furthermore, when extending out to both...
After a recent downward gap, BIIB looks to me to have established a new upward channel. With bullish MACD, great analyst ratings, a history of earnings beats, and the next earnings coming up in mid-July, BIIB should be up in the short-to-medium term. Set fairly tight stops to protect against a downward channel breakout. Here's my Biogen trading plan Monday...
In my previous post on #CRISPR I talked about the Green upward sloping trendline & how every time CRSPR has traded on or below it since May 2017 we've seen parabolic action. I don't want to say I told you so, but we've seen some parabolic action. To my surprise, the parabolic movement came the news of Vertex upfront payment of $175 million upfront payment....
After recapturing its 200 DMA back in March and subsequently vaulting from a 3 to 4 - handle, ZIOPHARM ONCOLOGY INC - NASDAQ:ZIOP has found itself in a sideways drift and appears to be building a base these past couple of months as we can observe from the Daily chart above. With the stock trading above all of its important moving averages 20/50/200 DMA's, ZIOP...
After breaking to higher ground in 1Q19 and subsequently drifting back down to its original break-out level in the upper teen's, the shares of AMARIN CORP NASDAQ: AMRN are once again starting to show signs of potentially setting-up for another attempt at loftier levels as evidenced in the Daily chart above. While AMRN presently finds itself in drift mode...
After breaking higher in early April on large volume, Chimerix Inc. (NASDAQ:CMRX) spent the next several weeks digesting/consolidating the move before breaking higher yet again last month (May) and in the process, recapturing its 200 DMA as evidenced in the Daily chart above. With the stock presently trading above all of its important moving averages (20/50/200...
Another pharma company - with amazing correct Elliot 5 waves which you can try to ride. 1. Buy 131.32 2. Take profit: 213 3. SL: 115.90 RISK/REWARD: 5.38, potential profit 62.39%
Since July 2017, every time CRSP has traded on or below the Green upward sloping trendline CRSP has seen some parabolic action. Time will tell per usual.
CRMD is lined up for a move much higher, and fast and slow MA's have both turned up now too.
weekly getting tight time to move, news in May June September
Shares of T2 Biosystems (TTOO) have fallen by roughly 75% since the company's IPO was priced at $11 in 2014. Over the past 3 years, the share price has lost roughly two-thirds of its value and so far 2019 has seen further decline. Technical argument Limited: it’s no easy task trying to evaluate identify trading opportunities in price trends and patterns seen in...
Summary PKTX is where CSBR was 3 years ago. PKTX's AAGP molecule is life changing. Data is coming. With that comes higher stock price. Those of you who have been following me the last few years, because of my call on Champions Oncology, CSBR, know that I have been predicting that ProtoKinetix PKTX is destined to be my next CSBR. The dynamics of each company...
MMHVW - do your own research - the share price has remained above the 49dma for the first time in a bullish manner. This could be signaling change in trend. I’m holding for time being.